The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.
本发明涉及用于诊断成像的对比剂,其具有延长血液滞留时间的特性。特别地,本发明涉及一种新型化合物,其特征为具有增强成像部分(
IEM);蛋白质血浆结合部分(PPBM);和延长血液半衰期部分(BH
EM)。本发明还涉及包括这些化合物的制药组合物以及使用这些化合物和组合物进行血液半衰期延长和诊断成像对比增强的方法。